Eagle Pharmaceuticals Inc-DE
EGRX72
$0.90arrow_drop_down54.77%-$1.09
High Value
Penny Stock
EGRX72
$0.90
arrow_drop_down54.77%Performance History
| Key Stats | |
|---|---|
| Open | $1.90 |
| Prev. Close | $1.99 |
| EPS | 0.85 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $7.12M |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.75 | 2.00 |
| 52 Week Range | 0.75 | 14.78 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | 0.85 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Eagle Pharmaceuticals Inc-DE (EGRX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Mr. Scott L. Tarriff
- Headquarters
- Woodcliff Lake
- Employees
- 134
- Exchange
- NASDAQ
Keep an eye on Eagle Pharmaceuticals Inc-DE
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the market capitalization of Eagle Pharmaceuticals Inc-DE (EGRX)?
Eagle Pharmaceuticals Inc-DE (EGRX) has a market capitalization of $7.13M. The average daily trading volume is 771.07K, indicating the stock's liquidity and investor engagement.
help
What is Eagle Pharmaceuticals Inc-DE's (EGRX) price per share?
The current price per share for Eagle Pharmaceuticals Inc-DE (EGRX) is $0.9. The stock has seen a price change of -$1.09 recently, indicating a -54.77% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Eagle Pharmaceuticals Inc-DE (EGRX)?
For Eagle Pharmaceuticals Inc-DE (EGRX), the 52-week high is $14.78, which is 1.54K% from the current price. The 52-week low is $0.75, the current price is 20% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Eagle Pharmaceuticals Inc-DE (EGRX) a growth stock?
Eagle Pharmaceuticals Inc-DE (EGRX) has shown an average price growth of -3.95% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eagle Pharmaceuticals Inc-DE as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Eagle Pharmaceuticals Inc-DE (EGRX) stock price performance year to date (YTD)?
As of the latest data, Eagle Pharmaceuticals Inc-DE (EGRX) has a year-to-date price change of -84.1%. Over the past month, the stock has experienced a price change of 37.99%. Over the last three months, the change has been -77.27%. Over the past six months, the figure is -77.89%. Looking at a longer horizon, the five-year price change stands at -98.5%.
help
Is Eagle Pharmaceuticals Inc-DE (EGRX) a profitable company?
Eagle Pharmaceuticals Inc-DE (EGRX) has a net income of -$2.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 70.01% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.94% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 84.56%, providing insight into the company's sales performance and growth. The gross profit is $221.67M. Operating income is noted at $80.96M. Furthermore, the EBITDA is $56.28M.